K-numberK244023
Device nameMAGENTIQ-COLO (ME-APDS)
ApplicantMagentiq Eye, Ltd.
Product codeQNP
Device classClass II
Decision dateJan 24, 2025
DecisionSubstantially Equivalent
Regulation876.1520
AI Summary extracted from FDA summary PDF · never regenerated
Intended use

MAGENTIQ-COLO (ME-APDS) is computer-aided detection software that assists endoscopists during colonoscopy by automatically detecting and highlighting regions of video consistent with colorectal polyps in real time. The system processes video from endoscopy cameras using deep machine learning algorithms and displays the results on a separate screen; it is intended as an adjunct to standard colonoscopy for screening and surveillance, not as a diagnostic tool or replacement for tissue sampling.

Technological characteristics

Both the subject device and predicate use a Computer-Aided Polyp Detection (CADe) engine to process video frames and indicate presence and location of detected lesions in real time during colonoscopy. The subject device is a modification that includes updated labeling identifying additional compatible endoscopy systems and modifications to hardware and software, but the AI algorithm remains identical to the predicate device.

Test standards cited

IEC 60601-1-2:2014 [Including AMD 1:2021] and TR 60601-4-2 Edition 1.0 2016-05 for EMC testing; IEC 60601-1 Edition 3.2 2020-08 CONSOLIDATED VERSION for electrical safety testing.

Substantial equivalence argument

The device has identical intended uses, indications, and technological principles as the predicate; the AI algorithm is unchanged. Non-clinical testing (pixel-level image quality, software validation, EMC, electrical safety) all showed expected results. Standalone performance testing on 212 colonoscopy videos with 702 polyps demonstrated similar or superior detection rates (99.7% recall on histology-verified polyps) with acceptable false positive rates (FPPF threshold 0.0333 achieved). The minor hardware and software modifications with additional compatible endoscopy systems do not alter the intended use or raise new safety/effectiveness issues; clinical validation from the predicate supports the subject device.

Extracted by AI from the official FDA summary PDF →
Source

View the full FDA submission: accessdata.fda.gov

Researching this as a predicate?
Want a transparent AI-ranking score, AI-discovered related predicates, ongoing safety and warning-letter monitoring, full predicate chain lineage, and a drafted SE rationale — all saved to your own project? That's what an account adds.
Start free trial →

Everything you need for a 510(k) submission. Nothing you don't.

14-day free trial. No setup. Cancel anytime.

Start free trial →
Building an AI or ML-enabled device? Predicate search, PCCP tracking, and AI-specific FDA intelligence — built exclusively for AI/ML devices. Try AIFDA Intel →